Daniel Getts, Myeloid Therapeutics CEO
Myeloid Therapeutics goes down under for new manufacturing site, with $66M local investment
Myeloid Therapeutics is looking across the Pacific to establish a new manufacturing site, and will be netting some major assistance from the local government as …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.